Found: 19
Select item for more details and to access through your institution.
Carfilzomib induces leukaemia cell apoptosis via inhibiting ELK1/ KIAA1524 (Elk-1/ CIP2A) and activating PP2A not related to proteasome inhibition.
- Published in:
- British Journal of Haematology, 2017, v. 177, n. 5, p. 726, doi. 10.1111/bjh.14620
- By:
- Publication type:
- Article
Corrigendum: Protein tyrosine phosphatase 1B targets PITX1/p120RasGAP thus showing therapeutic potential in colorectal carcinoma.
- Published in:
- Scientific Reports, 2017, p. 45612, doi. 10.1038/srep45612
- By:
- Publication type:
- Article
Protein tyrosine phosphatase 1B targets PITX1/p120RasGAP thus showing therapeutic potential in colorectal carcinoma.
- Published in:
- Scientific Reports, 2016, p. 35308, doi. 10.1038/srep35308
- By:
- Publication type:
- Article
Disrupting VEGF-A paracrine and autocrine loops by targeting SHP-1 suppresses triple negative breast cancer metastasis.
- Published in:
- Scientific Reports, 2016, p. 28888, doi. 10.1038/srep28888
- By:
- Publication type:
- Article
Cancerous Inhibitor of Protein Phosphatase 2A Mediates Bortezomib-Induced Autophagy in Hepatocellular Carcinoma Independent of Proteasome.
- Published in:
- PLoS ONE, 2013, v. 8, n. 2, p. 1, doi. 10.1371/journal.pone.0055705
- By:
- Publication type:
- Article
Erratum to: Novel sorafenib analogues induce apoptosis through SHP-1 dependent STAT3 inactivation in human breast cancer cells.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Serine/threonine protein phosphatase 5 is a potential therapeutic target in cholangiocarcinoma.
- Published in:
- Liver International, 2018, v. 38, n. 12, p. 2248, doi. 10.1111/liv.13887
- By:
- Publication type:
- Article
Obatoclax analog SC-2001 inhibits STAT3 phosphorylation through enhancing SHP-1 expression and induces apoptosis in human breast cancer cells.
- Published in:
- Breast Cancer Research & Treatment, 2014, v. 146, n. 1, p. 71, doi. 10.1007/s10549-014-3000-0
- By:
- Publication type:
- Article
Tamoxifen induces apoptosis through cancerous inhibitor of protein phosphatase 2A-dependent phospho-Akt inactivation in estrogen receptor-negative human breast cancer cells.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Novel sorafenib analogues induce apoptosis through SHP-1 dependent STAT3 inactivation in human breast cancer cells.
- Published in:
- 2013
- By:
- Publication type:
- journal article
CIP2A is a target of bortezomib in human triple negative breast cancer cells.
- Published in:
- 2012
- By:
- Publication type:
- journal article
RFX-1-dependent activation of SHP-1 inhibits STAT3 signaling in hepatocellular carcinoma cells.
- Published in:
- Carcinogenesis, 2014, v. 35, n. 12, p. 2807
- By:
- Publication type:
- Article
Canagliflozin inhibits growth of hepatocellular carcinoma via blocking glucose-influx-induced β-catenin activation.
- Published in:
- Cell Death & Disease, 2019, v. 10, n. 6, p. N.PAG, doi. 10.1038/s41419-019-1646-6
- By:
- Publication type:
- Article
Sorafenib and its derivative SC-49 sensitize hepatocellular carcinoma cells to CS-1008, a humanized anti-TNFRSF10B (DR5) antibody.
- Published in:
- British Journal of Pharmacology, 2013, v. 168, n. 3, p. 658, doi. 10.1111/j.1476-5381.2012.02212.x
- By:
- Publication type:
- Article
Sequential combination of docetaxel with a SHP-1 agonist enhanced suppression of p-STAT3 signaling and apoptosis in triple negative breast cancer cells.
- Published in:
- Journal of Molecular Medicine, 2017, v. 95, n. 9, p. 965, doi. 10.1007/s00109-017-1549-x
- By:
- Publication type:
- Article
Cancerous inhibitor of protein phosphatase 2A (CIP2A) is an independent prognostic marker in wild-type KRAS metastatic colorectal cancer after colorectal liver metastasectomy.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Sorafenib Action in Hepatitis B Virus X-Activated Oncogenic Androgen Pathway in Liver through SHP-1.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Sorafenib analogue SC-60 induces apoptosis through the SHP-1/ STAT3 pathway and enhances docetaxel cytotoxicity in triple-negative breast cancer cells.
- Published in:
- Molecular Oncology, 2017, v. 11, n. 3, p. 266, doi. 10.1002/1878-0261.12033
- By:
- Publication type:
- Article
SC-1, a sorafenib derivative, shows anti-tumor effects in osteogenic sarcoma cells.
- Published in:
- Journal of Orthopaedic Research, 2013, v. 31, n. 2, p. 335, doi. 10.1002/jor.22218
- By:
- Publication type:
- Article